SCHEMBL6403347

SCHEMBL6403347

N#CCSc1nnc(-c2ccc(F)cc2)[nH]1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.37
ALDH1A1 P00352 4/20 0.37
MEN1 O00255 3/20 0.37
LMNA P02545 2/20 0.37
MAPT P10636 1/20 0.37
GAA P10253 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
NPC1 O15118 3/20 0.35
RAB9A P51151 3/20 0.35
KDM4E B2RXH2 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
HPGD P15428 2/20 0.34
MAPK13 O15264 1/20 0.34
ALOX5 P09917 1/20 0.34
GCGR P47871 1/20 0.34
MAPK12 P53778 1/20 0.34
MAPK11 Q15759 1/20 0.34
MAPK14 Q16539 1/20 0.34
CTSB P07858 1/20 0.34
ERBB2 P04626 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6409048 0.84 ALDH1A1 (0.48) KMT2AALDH1A1MEN1LMNAMAPT
SCHEMBL6404879 0.81 ALDH1A1 (0.54) KMT2AALDH1A1MEN1MAPTGAA
SCHEMBL6404365 0.81 GRK6 (0.40) KMT2AALDH1A1MEN1
SCHEMBL6405965 0.75 KDM4E (0.47) KMT2AALDH1A1MEN1LMNAMAPT
SCHEMBL6410721 0.71 BCAT1 (0.40) KMT2AALDH1A1MEN1LMNAMAPT
SCHEMBL24317550 0.70 NPC1 (0.47) KMT2AALDH1A1MEN1MAPTGAA
SCHEMBL6404070 0.68 SCN9A (0.49) LMNAMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL23527231 0.68 ALDH1A1 (0.50) KMT2AALDH1A1MEN1MAPTGAA
SCHEMBL7513500 0.68 CA12 (0.35) ALDH1A1MAPTGAANPC1RAB9A
SCHEMBL13830898 0.67 MAPT (0.64) KMT2AALDH1A1MEN1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof AGRIUS GROUP, LLC. 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof ABCG2, ATP5ME, DNTT KMT2A 2263/4885ALDH1A1 720/4885MEN1 3562/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.